62 related articles for article (PubMed ID: 20705589)
1. Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression.
Liu X; Feng R
Acta Biochim Biophys Sin (Shanghai); 2010 Jul; 42(7):496-501. PubMed ID: 20705589
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of c-Src blocks oestrogen-induced apoptosis and restores oestrogen-stimulated growth in long-term oestrogen-deprived breast cancer cells.
Fan P; Agboke FA; McDaniel RE; Sweeney EE; Zou X; Creswell K; Jordan VC
Eur J Cancer; 2014 Jan; 50(2):457-68. PubMed ID: 24183378
[TBL] [Abstract][Full Text] [Related]
3. Leptin Promotes Expression of EMT-Related Transcription Factors and Invasion in a Src and FAK-Dependent Pathway in MCF10A Mammary Epithelial Cells.
Olea-Flores M; Zuñiga-Eulogio M; Tacuba-Saavedra A; Bueno-Salgado M; Sánchez-Carvajal A; Vargas-Santiago Y; Mendoza-Catalán MA; Pérez Salazar E; García-Hernández A; Padilla-Benavides T; Navarro-Tito N
Cells; 2019 Sep; 8(10):. PubMed ID: 31554180
[TBL] [Abstract][Full Text] [Related]
4. Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition.
Mejlvang J; Kriajevska M; Vandewalle C; Chernova T; Sayan AE; Berx G; Mellon JK; Tulchinsky E
Mol Biol Cell; 2007 Nov; 18(11):4615-24. PubMed ID: 17855508
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cellular and molecular markers of epithelial-mesenchymal transition by Brazilin in breast cancer cells.
Cayetano-Salazar L; Hernandez-Moreno JA; Bello-Martinez J; Olea-Flores M; Castañeda-Saucedo E; Ramirez M; Mendoza-Catalán MA; Navarro-Tito N
PeerJ; 2024; 12():e17360. PubMed ID: 38737746
[TBL] [Abstract][Full Text] [Related]
6. Machine learning reveals mesenchymal breast carcinoma cell adaptation in response to matrix stiffness.
Rozova VS; Anwer AG; Guller AE; Es HA; Khabir Z; Sokolova AI; Gavrilov MU; Goldys EM; Warkiani ME; Thiery JP; Zvyagin AV
PLoS Comput Biol; 2021 Jul; 17(7):e1009193. PubMed ID: 34297718
[TBL] [Abstract][Full Text] [Related]
7. Promyelocytic leukemia protein regulates angiogenesis and epithelial-mesenchymal transition to limit metastasis in MDA-MB-231 breast cancer cells.
Vogiatzoglou AP; Spanou S; Sachini N; Drakos E; Nikolaou C; Makatounakis T; Kretsovali A; Papamatheakis J
Mol Oncol; 2023 Oct; 17(10):2090-2108. PubMed ID: 37518985
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis.
Na YR; Seok SH; Kim DJ; Han JH; Kim TH; Jung H; Lee BH; Park JH
Cancer Sci; 2009 Nov; 100(11):2218-25. PubMed ID: 19735263
[TBL] [Abstract][Full Text] [Related]
9. Estradiol-Induced Epithelial to Mesenchymal Transition and Migration Are Inhibited by Blocking c-Src Kinase in Breast Cancer Cell Lines.
Jiménez-Salazar JE; Rivera-Escobar RM; Damián-Ferrara R; Maldonado-Cubas J; Rincón-Pérez C; Tarragó-Castellanos R; Damián-Matsumura P
J Breast Cancer; 2023 Oct; 26(5):446-460. PubMed ID: 37704382
[TBL] [Abstract][Full Text] [Related]
10. The lipid phenotype of breast cancer cells characterized by Raman microspectroscopy: towards a stratification of malignancy.
Nieva C; Marro M; Santana-Codina N; Rao S; Petrov D; Sierra A
PLoS One; 2012; 7(10):e46456. PubMed ID: 23082122
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of the contribution of ICAM-1 to epithelial-mesenchymal transition (EMT) in bladder cancer.
Zarzycka M; Kotula-Balak M; Gil D
Hum Cell; 2024 May; 37(3):801-816. PubMed ID: 38519725
[TBL] [Abstract][Full Text] [Related]
12. Dasatinib suppresses collective cell migration through the coordination of focal adhesion and
Lu YW; Hou XL; Koo HM; Chao WT
Heliyon; 2024 Jan; 10(1):e23501. PubMed ID: 38187289
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-to-Mesenchymal Transition-Related Markers in Prostate Cancer: From Bench to Bedside.
Gogola S; Rejzer M; Bahmad HF; Abou-Kheir W; Omarzai Y; Poppiti R
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190236
[TBL] [Abstract][Full Text] [Related]
14. An Ethanol Extract of
Jeong JH; Park HJ; Chi GY; Choi YH; Park SH
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110648
[TBL] [Abstract][Full Text] [Related]
15. Bufalin inhibits epithelial-mesenchymal transition and increases radiosensitivity of non-small cell lung cancer via inhibition of the Src signaling.
Wang Z; Liu F; Huang C; Zhang J; Wu J
J Thorac Dis; 2023 Jan; 15(1):123-134. PubMed ID: 36794138
[TBL] [Abstract][Full Text] [Related]
16. A Phase I Study of the Non-Receptor Kinase Inhibitor Bosutinib in Combination with Pemetrexed in Patients with Selected Metastatic Solid Tumors.
Karim NA; Ullah A; Wang H; Shoukier M; Pulliam S; Khaled A; Patel N; Morris JC
Curr Oncol; 2022 Dec; 29(12):9461-9473. PubMed ID: 36547158
[TBL] [Abstract][Full Text] [Related]
17. c-Src inhibitor PP2 inhibits head and neck cancer progression through regulation of the epithelial-mesenchymal transition.
Lee S; Park S; Ryu JS; Kang J; Kim I; Son S; Lee BS; Kim CH; Kim YS
Exp Biol Med (Maywood); 2023 Mar; 248(6):492-500. PubMed ID: 36527337
[TBL] [Abstract][Full Text] [Related]
18.
Chang CK; Chu SC; Huang JY; Chen PN; Hsieh YS
Front Pharmacol; 2022; 13():963589. PubMed ID: 36238547
[No Abstract] [Full Text] [Related]
19. Worm-Based Microfluidic Biosensor for Real-Time Assessment of the Metastatic Status.
Zhang J; Chua SL; Khoo BL
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669617
[TBL] [Abstract][Full Text] [Related]
20. How Different Are the Molecular Mechanisms of Nodal and Distant Metastasis in Luminal A Breast Cancer?
Lapcik P; Pospisilova A; Janacova L; Grell P; Fabian P; Bouchal P
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32947901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
